Summary & Overview
CPT 52354: Cystourethroscopy with Ureteroscopy/Pyeloscopy, Lesion Biopsy or Fulguration
CPT code 52354 covers cystourethroscopy with ureteroscopy and/or pyeloscopy when a ureteral or renal pelvic lesion is biopsied or fulgurated. This endoscopic urologic procedure combines diagnostic inspection of the bladder, urethra and upper urinary tract with a therapeutic or diagnostic intervention on a lesion. It is relevant nationally due to the frequency of upper urinary tract lesions, the need for tissue diagnosis, and the growing role of endoscopic management in urologic oncology and stone disease.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical and coding overview, typical sites of service, and the common billing and documentation considerations associated with endoscopic biopsy and fulguration of ureteral or pelvic lesions. The publication outlines expected service context, highlights payer coverage considerations at a national level, and explains what clinicians and billing staff should document to support use of CPT code 52354.
This summary is intended to orient clinicians, coding professionals, and policy analysts to the clinical intent of the code, the typical delivery setting, and the main topics covered in the full publication, including benchmarks, clinical context, and recent policy updates that affect endoscopic urologic procedures.
Billing Code Overview
CPT code 52354 describes a cystourethroscopy with ureteroscopy and/or pyeloscopy during which a ureteral or renal pelvic lesion is biopsied or destroyed by fulguration. The procedure involves endoscopic inspection of the bladder, urethra, prostatic urethra, ureteral orifices, ureters, and renal pelvis using a cystoscope passed through the urethra and into the bladder and then advancing a ureteroscope into the ureter or renal pelvis as needed.
-
Service type: Endoscopic diagnostic and therapeutic urologic procedure involving cystoscopy with ureteroscopy and/or pyeloscopy and biopsy or fulguration
-
Typical site of service: Ambulatory surgery center or hospital operating room; may also be performed in an endoscopy suite when appropriate
Clinical & Coding Specifications
Clinical Context
A 64-year-old male presents with painless gross hematuria and intermittent flank pain. Prior noninvasive imaging (CT urogram) identified a suspicious filling defect in the distal right ureter. The urology team schedules a diagnostic cystourethroscopy with ureteroscopy/pyeloscopy and possible biopsy or fulguration. The patient arrives to an ambulatory surgery center (ASC) or hospital outpatient department (HOPD) after preoperative evaluation, informed consent, and appropriate anesthesia assessment (general or spinal).
During the procedure the provider introduces a cystoscope through the urethra to inspect the urethra, prostatic urethra, and bladder. A semi-rigid or flexible ureteroscope is passed into the ureter for inspection of the ureter and renal pelvis. On identification of a ureteral or pelvic lesion, the surgeon obtains a biopsy for pathologic review or performs fulguration with high-frequency electric current to ablate the lesion. Specimens are sent to pathology; hemostasis is confirmed; a ureteral stent may be placed based on intraoperative findings. The postoperative workflow includes recovery, discharge instructions, pathology follow-up, and scheduling of stent removal if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Main or initial service | Use when this procedure is the primary service for the encounter. |
22 | Increased procedural services | Use when documented work substantially exceeds typical requirements (complexity, prolonged time). |
52 | Reduced services | Use when the procedure is partially reduced or not completed as planned. |
53 | Discontinued procedure | Use when the procedure is started but terminated due to extenuating circumstances or patient condition. |
59 | Distinct procedural service | Use to indicate a separate and distinct procedure when another service might be bundled. |
62 | Two surgeons | Use when two surgeons work together as primary surgeons performing distinct portions of the procedure. |
63 | Procedure performed on infants less than 4 kg | Use when applicable to neonatal patients matching weight criteria. |
73 | Discontinued outpatient hospital/ASC prior to anesthesia | Use when the procedure is cancelled after patient preparation but before anesthesia administration. |
74 | Discontinued outpatient hospital/ASC after anesthesia | Use when procedure is discontinued after anesthesia induction. |
76 | Repeat procedure by same physician | Use when the same physician repeats the procedure later during the postoperative period. |
77 | Repeat procedure by another physician | Use when a different physician repeats the same procedure during the postoperative period. |
78 | Return to the operating room for a related procedure during the global period | Use when reoperation is related to the original procedure during the global period. |
79 | Unrelated procedure during the global period | Use when an unrelated procedure is performed during the postoperative global period. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 208800000X | Urology | Most common specialty performing cystourethroscopy with ureteroscopy/pyeloscopy. |
| 2080P0207X | Female Pelvic Medicine & Reconstructive Surgery | May perform endoscopic bladder/ureter procedures in select patients. |
| 207R00000X | General Surgery | Some general surgeons with endourology training may perform ureteroscopy in select settings. |
| 207L00000X | Colon & Rectal Surgery | Rarely involved; included to reflect multidisciplinary pelvic surgeons who may perform cystoscopy in select cases. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
N13.2 | Hydronephrosis with ureteral stricture, not elsewhere classified | Ureteroscopy may be used to evaluate and sample strictured segments and assist in stent placement. |
N20.1 | Calculus of ureter | Ureteroscopy is commonly used to visualize and manage ureteral stones; code relevant when stone disease is found. |
C67.9 | Malignant neoplasm of bladder, unspecified | Cystoscopy portion evaluates bladder lesions; ureteral/pyeloscopic biopsy may be performed if metastatic or synchronous lesions suspected. |
C66.9 | Malignant neoplasm of ureter, unspecified | Direct indication for ureteroscopy with biopsy or fulguration for diagnosis and local control. |
R31.9 | Hematuria, unspecified | Hematuria is a common presenting symptom prompting cystourethroscopy and possible ureteroscopic evaluation. |
N13.6 | Pyonephrosis | Endoscopic evaluation of the ureter and renal pelvis may be required for drainage and culture/biopsy in infected obstructed systems. |
N28.9 | Disorder of kidney and ureter, unspecified | Broad code applicable when specific diagnosis is pending; endoscopic inspection helps define pathology. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
52000 | Cystourethroscopy, diagnostic, with or without collection of specimen(s) by brushing or washing | Often performed when only diagnostic cystoscopy is required without ureteroscopy; may precede or replace more advanced endoscopic procedures. |
52332 | Cystourethroscopy, with insertion of indwelling ureteral stent (eg, Gibbons or double-J) | May be performed during the same operative session to relieve obstruction or maintain drainage after ureteral manipulation or biopsy. |
52356 | Cystourethroscopy with ureteroscopy, with removal of ureteral calculus by ureteroscopy | Performed when ureteral stones are encountered and require extraction rather than biopsy or fulguration. |
52320 | Cystourethroscopy, with biopsy(s) of the bladder and/or urethra (separate procedure) | Used when additional bladder or urethral biopsies are taken in conjunction with ureteral/renal pelvis biopsy. |
50590 | Lithotripsy, ultrasonic shockwave, percutaneous renal stone fragmentation, including nephroscopy | May be part of the broader endourologic management when stones in the renal pelvis require percutaneous approaches following endoscopic evaluation. |